Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis

Abstract.Background: The spinal cord is a common site of involvement in multiple sclerosis (MS) where pathology contributes substantially to locomotor disability. Previous studies have demonstrated significant correlations between clinical disability and cervical cord atrophy, but not with cord T2 lesion load. We evaluate cervical cord pathology using, for the first time, quantitative T1 relaxation time (T1), which shows histopathological specificity for tissue damage in the cerebral white matter. Method: Cervical cord T1 was compared in 15 MS patients [8 relapsing-remitting (RR), 7 secondary progressive (SP)] and 6 healthy controls, and related to normalised upper cervical cord area (UCCa), cerebral white matter T1, T2 lesion load and disability measures including the Expanded Disability Status Scale (EDSS), Ambulation index (AI) and timed 25-foot walk. T1 maps of the brain and cervical cord were acquired using a high-resolution, 3-dimensional fast low-angle shot sequence. Dual-echo sequences were also obtained. Results: Median cervical cord T1 [mean (standard deviation)] was significantly greater in RR [854 [28] ms] (p = 0.0006) and SP patients [927 [67] ms] (p < 0.0001) compared with controls [888 [61] ms], and in SP vs. RR patients (p = 0.002). In the overall patient cohort, it correlated significantly with median cerebral white matter T1 (r = 0.7, p = 0.0046), UCCa (r = −0.87, p < 0.0001), but not T2 lesion loads. Both median cervical cord T1 and UCCa (respectively) correlated significantly with the EDSS (r = 0.55, p = 0.03; r = −0.54, p = 0.04), AI (r = 0.77, p = 0.001; r = −0.60, p = 0.02) and timed 25-foot walk (r = 0.56, p = 0.03; r = −0.55, p = 0.04). Conclusion: Cervical cord T1 distinguishes between MS subgroups and could also prove a useful surrogate outcome measure in MS. The relation of cervical cord T1 to cerebral white matter T1 suggests that cord pathology may be influenced by tissue damage upstream.

[1]  Peter Kapeller,et al.  Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study , 2001, Journal of Neurology.

[2]  A. Thompson,et al.  Spinal cord MRI using multi‐array coils and fast spin echo , 1993, Neurology.

[3]  H. Lassmann,et al.  Histopathology and the blood–cerebrospinal fluid barrier in multiple sclerosis , 1994, Annals of neurology.

[4]  A. Thompson,et al.  Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. , 1996, Brain : a journal of neurology.

[5]  Stephen M. Rao,et al.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure. , 1999, Brain : a journal of neurology.

[6]  F. Barkhof,et al.  Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.

[7]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[8]  R. Kinkel,et al.  Axonal loss in normal-appearing white matter in a patient with acute MS , 2001, Neurology.

[9]  R. Kinkel,et al.  A Wallerian degeneration pattern in patients at risk for MS , 2000, Neurology.

[10]  M. Palkovits,et al.  Axonal changes in chronic demyelinated cervical spinal cord plaques. , 2000, Brain : a journal of neurology.

[11]  M. Rovaris,et al.  Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[12]  H. Weiner,et al.  Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. , 1983, The New England journal of medicine.

[13]  W. Mcdonald,et al.  The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.

[14]  Yu-Chung N. Cheng,et al.  Magnetic Resonance Imaging: Physical Principles and Sequence Design , 1999 .

[15]  T. Kameyama,et al.  Morphometry of the normal cadaveric cervical spinal cord. , 1994, Spine.

[16]  R I Grossman,et al.  Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. , 1995, Radiology.

[17]  J. Kurtzke Disability Rating Scales in Multiple Sclerosis , 1984, Annals of the New York Academy of Sciences.

[18]  G. Barker,et al.  Spinal cord atrophy and disability in MS , 1998, Neurology.

[19]  F. Ikuta,et al.  Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States , 1976, Neurology.

[20]  G. Comi,et al.  Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. , 1999, AJNR. American journal of neuroradiology.

[21]  F Barkhof,et al.  Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. , 1997, Magnetic resonance imaging.

[22]  G J Barker,et al.  Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations , 2001, Neurology.

[23]  F Barkhof,et al.  Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy , 1999, Annals of neurology.

[24]  D. N. Landon,et al.  Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[25]  Paul S. Morgan,et al.  White matter T1 relaxation time histograms and cerebral atrophy in multiple sclerosis , 2002, Journal of the Neurological Sciences.

[26]  P M Matthews,et al.  Magnetic resonance imaging of multiple sclerosis: new insights linking pathology to clinical evolution , 2001, Current opinion in neurology.

[27]  Ganter,et al.  Spinal cord axonal loss in multiple sclerosis: a post‐mortem study , 1999, Neuropathology and applied neurobiology.

[28]  MTR and T1 provide complementary information in MS NAWM, but not in lesions , 2000, Multiple sclerosis.

[29]  L. Guttmann Spinal cord injuries: comprehensive management and research , 1973 .

[30]  P. Scheltens,et al.  MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. , 1997, AJNR. American journal of neuroradiology.

[31]  B. Trapp,et al.  Pathogenesis of tissue injury in MS lesions , 1999, Journal of Neuroimmunology.

[32]  R. Rudick,et al.  Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients , 2000, Annals of neurology.

[33]  R. Knobler,et al.  Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. , 1995, Radiology.

[34]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[35]  David H. Miller,et al.  The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis , 2002, Journal of Neurology.

[36]  M. Horsfield,et al.  Dynamic T1 measurement using snapshot-FLASH MRI. , 1997, Journal of magnetic resonance.

[37]  P. S. Tofts,et al.  Towards quantitative measurements of relaxation times and other parameters in the brain , 2004, Neuroradiology.

[38]  G. Barker,et al.  Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations , 2000, Journal of neurology, neurosurgery, and psychiatry.

[39]  M. Horsfield,et al.  A conventional and magnetization transfer MRI study of the cervical cord in patients with MS , 2000, Neurology.

[40]  B. Trapp,et al.  Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences , 2001, Current opinion in neurology.

[41]  W. I. McDonald,et al.  Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis , 1996, Neurology.

[42]  C. Tanaka,et al.  Proton nuclear magnetic resonance studies on brain edema. , 1982, Journal of neurosurgery.